Differential Diagnosis and Misdiagnosis of Inclusion Body Myositis
Misdiagnosis is common with inclusion body myositis. IBM is rare and not well known among most physicians, and the symptoms can overlap with other conditions. Misdiagnosis matters because it can lead to unnecessary anxiety, unnecessary testing, and—in some cases—treatments that are not helpful for IBM.
Physicians use the term “differential diagnosis” to refer to a list of diseases or conditions that “look alike” because they cause similar symptoms and findings. The physician must consider all these conditions before making a final diagnosis. Some mimics are primarily muscle diseases, some are nerve diseases, some are medication-related, and some are genetic. This is why diagnosis often requires combining the patient’s story with the physical exam and supportive tests.
Most people reading this page will never have these conditions—this list exists because doctors need to think broadly before confirming IBM.
Aging and Sarcopenia
Aging is the most common misdiagnosis. Many, perhaps most, IBM patients are initially told, “You’re just getting older." Early weakness is often brushed aside by the patients, family, and physicians as simply a sign of aging. This is a mentality that must change. Loss of function due to weak muscles is not a normal, expected outcome of aging. Frequent falls are not normal. Inability to stand up from a chair is not normal. These symptoms demand a search for a medical explanation.
Sarcopenia is the medical term for an abnormal loss of muscle mass and function associated with aging. Causes can include lack of exercise, poor nutrition, obesity, and chronic illnesses.
Polymyositis
Polymyositis is an inflammatory muscle disease that especially affects the proximal muscles (those close to the trunk, such as the hip and shoulder muscles). It progresses more rapidly than IBM, tends to occur at a younger age, and often responds to treatment with immune-suppressing medications. Many inclusion body myositis patients are initially diagnosed as having polymyositis. The distinction is important, especially since it appears that inclusion body myositis patients treated with immunosuppressive drugs may have worse outcomes than those who are not treated.
PM-Mito (Polymyositis with Mitochondrial Pathology)
PM-Mito is a term sometimes used when a muscle biopsy shows signs of muscle inflammation along with unusually prominent changes in the muscle’s ‘energy factories’ (mitochondria). Some experts have proposed that PM-Mito can represent an early form of IBM in at least some patients, rather than a completely separate disease. In some published studies, many PM-Mito patients later meet clinical or biopsy criteria for IBM. For patients, the practical takeaway is that an early biopsy label may change over time as the disease evolves and becomes more clearly recognizable as IBM.
Other Inflammatory Myopathies
Several other inflammatory myopathies can resemble IBM at certain stages, especially early on. Dermatomyositis can sometimes be confusing when skin findings are subtle or overlooked. Immune-mediated necrotizing myopathy can also present with significant weakness, and it may be associated with certain autoantibodies or exposure to statins. Antisynthetase syndrome is another important diagnosis to consider, especially when there are lung symptoms or specific blood test findings. These conditions matter because their treatment approach and expected response to immunosuppression can differ from IBM.
Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic lateral sclerosis (ALS) is a nerve disease, not a muscle disease, but the symptoms can be similar. ALS progresses more rapidly, and many patients die within a few years. Some IBM patients are mistakenly diagnosed as having ALS, confronting patients with a severe psychological burden and sometimes compelling them to make unnecessary end-of-life decisions. The EMG (electromyography) is sometimes the source of the confusion, because IBM can occasionally produce EMG findings that resemble a nerve disorder—interpretation by an experienced neuromuscular specialist is important.
Other Neurologic Mimics
A number of other neurologic conditions can be considered in the differential diagnosis, depending on the pattern of weakness. Some peripheral nerve disorders and motor neuron disorders can overlap symptomatically with IBM. Examples include cervical spondylotic myelopathy (spinal cord compression in the neck), lumbar spinal stenosis or radiculopathy (pinched nerve roots), peripheral neuropathy, and chronic inflammatory demyelinating polyneuropathy (CIDP—a treatable immune neuropathy). Prior neurologic injury (such as childhood polio) can also contribute to progressive weakness later in life.
Muscular Dystrophies and Genetic Myopathies
Some inherited muscle diseases can resemble IBM clinically, and some can also show biopsy findings that overlap with IBM (such as vacuoles or protein clumps). Oculopharyngeal muscular dystrophy (OPMD) is a classic example because it can cause prominent swallowing difficulty and may present later in life. Certain genetic myopathies (including disorders related to VCP) can also be confused with IBM in some settings. Family history, the pattern of muscle involvement, and genetic testing can be decisive.
Medication-Related and Toxic Myopathies
Some medications can cause muscle weakness that may be mistaken for IBM. Hydroxychloroquine is one important example because it can cause a toxic myopathy and may be associated with swallowing symptoms in some patients. Statins can also be involved in certain immune-mediated muscle diseases. A careful medication history is always important, especially when symptoms begin after a medication change or when weakness progresses unusually quickly.
Metabolic Myopathies
A small number of metabolic muscle diseases can mimic aspects of IBM. Metabolic diseases are conditions in which the body’s cells have trouble processing or using energy normally, often because a specific enzyme or cellular pathway is not working properly. Adult-onset Pompe disease is one example; it can cause limb-girdle weakness (hip and shoulder weakness) and may have additional clues such as respiratory involvement. Another example is McArdle disease, which can cause marked exercise intolerance and muscle pain. These conditions are important to consider because specific tests exist, and treatment implications can be very different.
Reasons for Misdiagnosis of Inclusion Body Myositis
Misdiagnosis of inclusion body myositis is often due to overreliance on muscle biopsy findings. Failure to identify rimmed vacuoles in a muscle biopsy does not invalidate the diagnosis of IBM. The biopsy is an important test, but the significance of the patient’s symptoms and physical exam findings must not be discarded in the face of an equivocal biopsy.
Confusion can also be caused by less common patterns of muscle involvement, such as isolated swallowing difficulty, or lack of quadriceps weakness.
Inclusion body myositis is a rare disease and is often difficult to diagnose. Suspected cases may benefit from referral to a neuromuscular disease center.
For an overview of the key findings used to diagnose IBM, see: Diagnosis of Inclusion Body Myositis.
Selected academic references:
Revised March 4, 2026